In this scenario, the decreased adiponectin secreted levels and the dysregulated expression of AdipoRs in breast tumor cells and TME cell components are gaining increasing attention to understand the molecular mechanisms that drive the growth and progression of breast cancer, as well as to identify new therapeutic targets [79,81,101,102]. The gene discussed is ADIPOQ; the disease is breast neoplasm.